DK3326622T3 - Modificerede peptider og deres anvendelse ved hæmning af AXL-signalering inden for anti-metastaseterapi - Google Patents
Modificerede peptider og deres anvendelse ved hæmning af AXL-signalering inden for anti-metastaseterapi Download PDFInfo
- Publication number
- DK3326622T3 DK3326622T3 DK17196662.5T DK17196662T DK3326622T3 DK 3326622 T3 DK3326622 T3 DK 3326622T3 DK 17196662 T DK17196662 T DK 17196662T DK 3326622 T3 DK3326622 T3 DK 3326622T3
- Authority
- DK
- Denmark
- Prior art keywords
- modified peptides
- axl signaling
- inhibiting axl
- metastasis therapy
- metastasis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/10—Protein-tyrosine kinases (2.7.10)
- C12Y207/10001—Receptor protein-tyrosine kinase (2.7.10.1)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261737276P | 2012-12-14 | 2012-12-14 | |
| EP13862780.7A EP2931265B3 (en) | 2012-12-14 | 2013-12-12 | Modified axl peptides and their use in inhibition of axl signaling in anti-metastatic therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3326622T3 true DK3326622T3 (da) | 2021-04-06 |
Family
ID=50934967
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17196662.5T DK3326622T3 (da) | 2012-12-14 | 2013-12-12 | Modificerede peptider og deres anvendelse ved hæmning af AXL-signalering inden for anti-metastaseterapi |
| DK13862780.7T DK2931265T6 (da) | 2012-12-14 | 2013-12-12 | Modificerede AXL-petider og deres anvendelse til inhibering af AXL-signalering i en antimetastatisk terapi |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13862780.7T DK2931265T6 (da) | 2012-12-14 | 2013-12-12 | Modificerede AXL-petider og deres anvendelse til inhibering af AXL-signalering i en antimetastatisk terapi |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US9822347B2 (enExample) |
| EP (2) | EP3326622B1 (enExample) |
| JP (2) | JP6345690B2 (enExample) |
| AU (3) | AU2013359179B2 (enExample) |
| CA (1) | CA2894539C (enExample) |
| DK (2) | DK3326622T3 (enExample) |
| ES (2) | ES2862335T3 (enExample) |
| FI (1) | FI2931265T6 (enExample) |
| NO (1) | NO3049208T3 (enExample) |
| PT (2) | PT3326622T (enExample) |
| WO (1) | WO2014093690A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9074192B2 (en) * | 2010-01-22 | 2015-07-07 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of AXL signaling in anti-metastatic therapy |
| RU2556822C2 (ru) * | 2010-01-22 | 2015-07-20 | Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити | Ингибирование axl сигнализации в антиметастатической терапии |
| WO2013090776A1 (en) | 2011-12-15 | 2013-06-20 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of axl/gas6 signaling in the treatment of disease |
| FI2931265T6 (fi) | 2012-12-14 | 2023-05-23 | Muokattuja axl-peptidejä ja niiden käyttö axl-viestinvälityksen estossa etäispesäkkeitä estävässä hoidossa | |
| CA2909669C (en) | 2014-10-20 | 2023-12-12 | Ruga Corporation | Antiviral activity of gas6 inhibitor |
| EP3233902B1 (en) * | 2014-12-18 | 2020-09-09 | Aravive Biologics, Inc. | Antifibrotic activity of gas6 inhibitor |
| KR20200085307A (ko) * | 2017-11-04 | 2020-07-14 | 아라바이브 바이올로직스, 인크. | Axl 유인 수용체를 이용한 전이성 암의 치료 방법 |
| JP2024533362A (ja) * | 2021-09-11 | 2024-09-12 | アラヴィヴ インコーポレイテッド | Ａｘｌデコイ受容体を一次治療として使用する局所進行又は転移性膵臓腺がんを治療する方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| EP0394827A1 (en) | 1989-04-26 | 1990-10-31 | F. Hoffmann-La Roche Ag | Chimaeric CD4-immunoglobulin polypeptides |
| US5538861A (en) | 1994-07-29 | 1996-07-23 | Amgen Inc. | DNA encoding a stimulating factor for the axl receptor |
| US20030166107A1 (en) | 1997-09-18 | 2003-09-04 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US6737056B1 (en) * | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| EP1382969A1 (en) | 2002-07-17 | 2004-01-21 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Diagnosis and prevention of cancer cell invasion |
| AU2003304180A1 (en) | 2002-09-24 | 2005-01-04 | Dow, Kenneth, Centocor, Inc. | Growth arrest specific gene 6 peptides, antibodies, compositions, methods and uses |
| US20070142273A1 (en) | 2003-04-18 | 2007-06-21 | Sherif Daouti | Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis |
| JP2005278631A (ja) | 2004-03-04 | 2005-10-13 | National Institute Of Advanced Industrial & Technology | Ａｘｌリガンド結合領域蛋白質、その製造方法及びそれを用いたスクリーニング方法 |
| CA2630475A1 (en) | 2004-11-24 | 2006-06-01 | The Regents Of The University Of Colorado | Mer diagnostic and therapeutic agents |
| US7932032B2 (en) | 2005-05-02 | 2011-04-26 | Toray Industries, Inc. | Method for diagnosing esophageal cancer |
| US8168415B2 (en) * | 2007-02-07 | 2012-05-01 | The Regents Of The University Of Colorado | Axl fusion proteins as Axl tyrosine kinase inhibitors |
| CN101679313A (zh) | 2007-04-13 | 2010-03-24 | 休普基因公司 | 用于治疗癌症或过度增殖性疾病的axl激酶抑制剂 |
| CA2692320A1 (en) | 2007-07-02 | 2009-01-08 | Wyeth | Methods of treating bone disorders with modulators of axl |
| US20120230991A1 (en) | 2008-07-29 | 2012-09-13 | Douglas Kim Graham | Methods and compounds for enhancing anti-cancer therapy |
| CA2747678A1 (en) * | 2008-12-19 | 2010-06-24 | Novartis Ag | Soluble polypeptides for use in treating autoimmune and inflammatory disorders |
| KR20120035145A (ko) | 2009-05-11 | 2012-04-13 | 우드라이 파마 게엠베하 | 인간화 ａｘｌ 항체 |
| US9074192B2 (en) * | 2010-01-22 | 2015-07-07 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of AXL signaling in anti-metastatic therapy |
| RU2556822C2 (ru) * | 2010-01-22 | 2015-07-20 | Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити | Ингибирование axl сигнализации в антиметастатической терапии |
| AU2011326164B2 (en) | 2010-11-08 | 2016-05-05 | The Board Of Trustees Of The Leland Stanford Junior University | Fusion proteins comprising an engineered knottin peptide and uses thereof |
| WO2013090776A1 (en) * | 2011-12-15 | 2013-06-20 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of axl/gas6 signaling in the treatment of disease |
| US20150315552A1 (en) | 2012-12-14 | 2015-11-05 | The Board Of Trustees Of The Leland Stanford Junior University | Inhibition of AXL Signaling in Primary Tumor Therapy |
| FI2931265T6 (fi) | 2012-12-14 | 2023-05-23 | Muokattuja axl-peptidejä ja niiden käyttö axl-viestinvälityksen estossa etäispesäkkeitä estävässä hoidossa | |
| US20160266136A1 (en) * | 2013-08-30 | 2016-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | High-affinity binding to gas6 |
| CA2909669C (en) * | 2014-10-20 | 2023-12-12 | Ruga Corporation | Antiviral activity of gas6 inhibitor |
| EP3233902B1 (en) * | 2014-12-18 | 2020-09-09 | Aravive Biologics, Inc. | Antifibrotic activity of gas6 inhibitor |
-
2013
- 2013-12-12 FI FIEP13862780.7T patent/FI2931265T6/fi active
- 2013-12-12 US US14/650,854 patent/US9822347B2/en active Active
- 2013-12-12 AU AU2013359179A patent/AU2013359179B2/en not_active Ceased
- 2013-12-12 WO PCT/US2013/074786 patent/WO2014093690A1/en not_active Ceased
- 2013-12-12 EP EP17196662.5A patent/EP3326622B1/en active Active
- 2013-12-12 JP JP2015547567A patent/JP6345690B2/ja active Active
- 2013-12-12 ES ES17196662T patent/ES2862335T3/es active Active
- 2013-12-12 DK DK17196662.5T patent/DK3326622T3/da active
- 2013-12-12 EP EP13862780.7A patent/EP2931265B3/en active Active
- 2013-12-12 PT PT171966625T patent/PT3326622T/pt unknown
- 2013-12-12 PT PT138627807T patent/PT2931265T/pt unknown
- 2013-12-12 CA CA2894539A patent/CA2894539C/en active Active
- 2013-12-12 DK DK13862780.7T patent/DK2931265T6/da active
- 2013-12-12 ES ES13862780T patent/ES2665323T7/es active Active
-
2014
- 2014-06-30 NO NO14741534A patent/NO3049208T3/no unknown
-
2017
- 2017-10-13 US US15/783,850 patent/US11136563B2/en not_active Expired - Fee Related
- 2017-12-06 AU AU2017272193A patent/AU2017272193A1/en not_active Abandoned
-
2018
- 2018-05-23 JP JP2018098435A patent/JP6832887B2/ja not_active Expired - Fee Related
-
2019
- 2019-08-02 AU AU2019210662A patent/AU2019210662B2/en not_active Ceased
-
2021
- 2021-09-02 US US17/465,203 patent/US20220220458A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DK2931265T3 (en) | 2018-04-16 |
| FI2931265T6 (fi) | 2023-05-23 |
| ES2665323T7 (es) | 2023-06-15 |
| EP3326622B1 (en) | 2021-01-20 |
| AU2013359179B2 (en) | 2017-10-05 |
| ES2862335T3 (es) | 2021-10-07 |
| AU2017272193A1 (en) | 2017-12-21 |
| AU2013359179A1 (en) | 2015-07-02 |
| WO2014093690A1 (en) | 2014-06-19 |
| US9822347B2 (en) | 2017-11-21 |
| DK2931265T6 (da) | 2023-05-01 |
| NO3049208T3 (enExample) | 2018-04-14 |
| CA2894539C (en) | 2021-09-28 |
| JP6832887B2 (ja) | 2021-02-24 |
| ES2665323T3 (es) | 2018-04-25 |
| CA2894539A1 (en) | 2014-06-19 |
| US20150315553A1 (en) | 2015-11-05 |
| US20180030422A1 (en) | 2018-02-01 |
| AU2019210662A1 (en) | 2019-08-22 |
| US11136563B2 (en) | 2021-10-05 |
| EP2931265A1 (en) | 2015-10-21 |
| HK1256071A1 (en) | 2019-09-13 |
| PT3326622T (pt) | 2021-04-07 |
| EP2931265A4 (en) | 2016-08-31 |
| JP2016510309A (ja) | 2016-04-07 |
| PT2931265T (pt) | 2018-04-16 |
| EP2931265B1 (en) | 2018-01-31 |
| US20220220458A1 (en) | 2022-07-14 |
| EP2931265B3 (en) | 2023-04-05 |
| EP3326622A1 (en) | 2018-05-30 |
| JP6345690B2 (ja) | 2018-06-20 |
| AU2019210662B2 (en) | 2021-07-01 |
| JP2018154641A (ja) | 2018-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3608325T3 (da) | Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse | |
| DK3326622T3 (da) | Modificerede peptider og deres anvendelse ved hæmning af AXL-signalering inden for anti-metastaseterapi | |
| DK3088353T3 (da) | Bilirubinpartikler og deres fremstilling til anvendelse i terapi | |
| DK2920197T3 (da) | Prolinlåste sammenhæftede peptider og anvendelser deraf | |
| DK2920313T3 (da) | Rekombinante adenovira og anvendelse deraf | |
| DK2855736T3 (da) | Elektrolysator og energisystem | |
| DK3597644T3 (da) | Kationiske aminlipider og anvendelser deraf | |
| DK2872419T3 (da) | Fordelingsbeholder og tilsvarende fremgangsmåde | |
| DK3346008T3 (da) | Rekombinante mikroorganismer og anvendelser deraf | |
| DK3196022T3 (da) | Trykningssystem og fremgangsmåde | |
| BR112013021524A2 (pt) | micro-organismos recombinantes e usos dos mesmos | |
| DK3358011T3 (da) | Peptid til inducering af regenerering af væv og anvendelse deraf | |
| DK3202760T3 (da) | Pegylerede lipider og deres anvendelse til lægemiddelfremføring | |
| HRP20182037T1 (hr) | Inhibitori prmt5 i njihova uporaba | |
| BR112014021287A2 (pt) | Grampo cirúrgico | |
| DK2579877T3 (da) | Morpholinopyrimidiner og deres anvendelse til terapi | |
| EP2877109A4 (en) | SYSTEM AND VERTEBRAL COLUMN ASSEMBLY | |
| DK2903600T3 (da) | Virusholdig formulering og anvendelse deraf | |
| DK2850202T3 (da) | Fremgangsmåder og grupper | |
| DK2812356T3 (da) | CDIM-bindende proteiner og anvendelser deraf | |
| DK3269386T3 (da) | Aluminiumforbindelser til anvendelse inden for behandling og i vacciner | |
| DK2815769T3 (da) | Fam19a5 til anvendelse i diagnosticering og behandling af skader på centralnervesystemet | |
| BR112014003774A2 (pt) | inibidores de dyrk1 e usos dos mesmos | |
| IL232262A0 (en) | Therapeutic agents and uses thereof | |
| DK3065759T3 (da) | Immunosuppressive midler og deres anvendelse i terapi |